ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 56 filers reported holding ERASCA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,302,095 | -28.6% | 10,813,246 | 0.0% | 1.24% | -25.7% |
| Q2 2023 | $29,844,559 | +91594.0% | 10,813,246 | 0.0% | 1.67% | -22.0% |
| Q1 2023 | $32,548 | -30.2% | 10,813,246 | 0.0% | 2.14% | -31.3% |
| Q4 2022 | $46,605 | -99.9% | 10,813,246 | +2.9% | 3.12% | -45.5% |
| Q3 2022 | $81,943,000 | +40.0% | 10,505,554 | 0.0% | 5.73% | +29.5% |
| Q2 2022 | $58,516,000 | -35.2% | 10,505,554 | 0.0% | 4.42% | -36.2% |
| Q1 2022 | $90,348,000 | -44.8% | 10,505,554 | +0.0% | 6.94% | -28.7% |
| Q4 2021 | $163,676,000 | -24.5% | 10,505,550 | 0.0% | 9.74% | +10.5% |
| Q3 2021 | $216,845,000 | – | 10,505,550 | – | 8.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 11,055,554 | $21,779,441 | 14.15% |
| EDBI Pte Ltd | 888,888 | $1,751,109 | 1.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,926,000 | $3,794,220 | 1.28% |
| Cormorant Asset Management, LP | 10,813,246 | $21,302,095 | 1.24% |
| AH Equity Partners LSV II, L.L.C. | 312,500 | $615,625 | 0.64% |
| Artal Group S.A. | 4,721,194 | $9,301 | 0.40% |
| PFM Health Sciences, LP | 3,930,633 | $7,743,347 | 0.36% |
| ARMISTICE CAPITAL, LLC | 8,356,000 | $16,461,320 | 0.25% |
| SANDERS MORRIS HARRIS LLC | 425,297 | $816,569 | 0.17% |
| Prosight Management, LP | 264,710 | $521,479 | 0.16% |